C
Gamehost Inc. GH.TO
TSX
Recommendation
Prev Close
$11.85
Volume
--
Avg Vol (90D)
3,474
Market Cap
$175.94M
Dividend & Yield
$0.58(4.89%)
52-Week Range
$9.30 - $12.60
P/E (TTM)
16.71
EPS (TTM)
$0.7091
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4 Healthcare Stocks With Massive Gains—and More to Come
3/29/2025 - MarketBeat
How Investors Are Reacting To Guardant Health (GH) FDA Approval for New Breast Cancer Companion Test
10/3/2025 - Simply Wall St
Barclays Raises Price Target for Guardant Health (GH) to $70.00 GH Stock News
10/2/2025 - GuruFocus
Guardant Health price target raised by $10 at Barclays, here's why
10/2/2025 - The Fly
4,782 Shares in Guardant Health, Inc. $GH Purchased by Trivium Point Advisory LLC
10/2/2025 - MarketBeat
Sicart Associates LLC Increases Stock Holdings in Guardant Health, Inc. $GH
10/1/2025 - MarketBeat
Guardant Health, Inc. (GH) Unveils Shield V2, Boosts Early Cancer Detection Accuracy
9/30/2025 - Yahoo! Finance: News
Guardant Health, Inc. (GH) Unveils Shield V2, Boosts Early Cancer Detection Accuracy
9/30/2025 - Insider Monkey
Guardant Health (GH, $61.99) Stochastic Oscillator left the overbought zone on September 29, 2025
9/30/2025 - Tickeron - Stocks
Guardant Health (GH, $61.99) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 29, 2025
9/30/2025 - Tickeron - Stocks
Guardant Health (GH) Secures FDA Approval for Diagnostic Test
9/29/2025 - GuruFocus
Guardant Health gets FDA nod for Guardant360 CDx as a companion diagnostic
9/29/2025 - Seeking Alpha - Healthcare
Guardant Health gets FDA nod for Guardant360 CDx as a companion diagnostic
9/29/2025 - SeekingAlpha.com: All News
Guardant Health (GH) Secures FDA Approval for Breast Cancer Diagnostic Tool
9/29/2025 - GuruFocus
Guardant Health announces FDA approved Guardant360 CDx
9/29/2025 - The Fly
FDA Approves Guardant360 CDx as Companion Diagnostic for Eli Lilly and Companys Inluriyo (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer
9/29/2025 - Business Wire
SWS Partners Cuts Stock Holdings in Guardant Health, Inc. $GH
9/29/2025 - MarketBeat
Guardant Health (NASDAQ:GH) Price Target Raised to $75.00
9/29/2025 - Ticker Report
12 Best Performing Healthcare Stocks to Buy Right Now
9/29/2025 - Insider Monkey
Guardant Health (GH): Valuation Spotlight as Quest Deal Expands Shield Test Access and Fuels Growth Optimism
9/27/2025 - Simply Wall St
Jefferies Remains a Buy on Guardant Health (GH)
9/27/2025 - TipRanks Financial Blog
Canaccord Genuity Raises Price Target for Guardant Health (GH) to $75 GH Stock News
9/26/2025 - GuruFocus
Canaccord Genuity Group Issues Positive Forecast for Guardant Health (NASDAQ:GH) Stock Price
9/26/2025 - MarketBeat
Guardant Health price target raised by $10 at Canaccord, here's why
9/26/2025 - The Fly
GH: TD Cowen Raises Price Target on Guardant Health to $72 GH Stock News
9/25/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$59.86M
EBITDA (TTM)
$23.58M
EBIT (TTM)
$20.89M
Net Income (TTM)
$14.90M
Balance Sheet
Total Assets (Q)
$128.76M
Total Debt (Q)
$33.65M
Total Liabilities (Q)
$44.36M
Book Value Per Share (Q)
$4.08
Cash Flow
Cash from Operations (TTM)
$18.68M
Cash from Investing (TTM)
-$943.40K
Cash from Financing (TTM)
-$17.22M
Net Change in Cash (TTM)
$523.60K
Filings
Filing Date
Tuesday, August 12, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Loading...
Beta
0.09
7-Day Total Return
-0.51%
30-Day Total Return
0.60%
60-Day Total Return
-6.35%
90-Day Total Return
7.83%
Year to Date Total Return
17.55%
1-Year Total Return
12.52%
2-Year Total Return
37.94%
3-Year Total Return
58.50%
5-Year Total Return
147.61%
52-week Low
Apr 10, 2025 - $9.30
52-week High
Jul 07, 2025 - $12.60
Valuation
Market Cap
$175.94M - Micro Cap
Enterprise Value
$197.95M
Price/Sales (TTM)
4.12
Price/Book (Q)
2.91
Dividends and Shares
Shares Outstanding
20.83
Dividend Per Share (Most Recent)
$0.05
Dividend Per Share (TTM)
$0.58
Corporate Info
Website
www.gamehost.ca
Phone Number
403 346 4545
Address
548 Laura Avenue
Red Deer County, AB T4E 0A5
Country
Canada
Year Founded
2003
Business Description
Sector
Consumer Discretionary
Industry
Consumer Services
Gamehost Inc., together with its subsidiaries, engages in the hospitality and gaming businesses in Alberta. It operates through Gaming, Hotel, and Food and Beverage segments. The company’s gaming... more